company background image
NZYM B

Novozymes CPSE:NZYM B Stock Report

Last Price

kr.362.80

Market Cap

kr.99.8b

7D

1.4%

1Y

-0.7%

Updated

11 Dec, 2023

Data

Company Financials +

NZYM B Stock Overview

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in North America, India, Japan, the Middle East, Africa, South East Asia, Latin America, and internationally.

NZYM B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends2/6

Rewards

Risk Analysis

NZYM B passed our risk checks.

Novozymes A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Novozymes
Historical stock prices
Current Share Pricekr.362.80
52 Week Highkr.400.00
52 Week Lowkr.274.60
Beta0.45
1 Month Change5.74%
3 Month Change19.38%
1 Year Change-0.71%
3 Year Change6.33%
5 Year Change22.94%
Change since IPO1,019.75%

Recent News & Updates

These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Sep 27
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Recent updates

These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Sep 27
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued

Sep 05
An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued

Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Jun 24
Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

May 02
Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Apr 07
Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Mar 26
Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?

Mar 12
Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?

Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues

Feb 04
Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues

Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Jan 29
Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Dec 23
Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture

Dec 05
Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture

A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

Oct 14
A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Sep 13
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence

Aug 29
The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence

Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Jul 13
Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Jun 13
Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

May 29
Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

Estimating The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

Apr 12
Estimating The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Mar 01
Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

Feb 14
Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

Is Novozymes A/S (CPH:NZYM B) Worth kr.537 Based On Its Intrinsic Value?

Jan 01
Is Novozymes A/S (CPH:NZYM B) Worth kr.537 Based On Its Intrinsic Value?

We Think Novozymes (CPH:NZYM B) Can Stay On Top Of Its Debt

Nov 28
We Think Novozymes (CPH:NZYM B) Can Stay On Top Of Its Debt

Many Would Be Envious Of Novozymes' (CPH:NZYM B) Excellent Returns On Capital

Nov 11
Many Would Be Envious Of Novozymes' (CPH:NZYM B) Excellent Returns On Capital

Is Novozymes A/S (CPH:NZYM B) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 25
Is Novozymes A/S (CPH:NZYM B) Expensive For A Reason? A Look At Its Intrinsic Value

Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Aug 23
Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Returns On Capital Signal Tricky Times Ahead For Novozymes (CPH:NZYM B)

Aug 05
Returns On Capital Signal Tricky Times Ahead For Novozymes (CPH:NZYM B)

Is Novozymes (CPH:NZYM B) Using Too Much Debt?

May 25
Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Novozymes (CPH:NZYM B) May Have Issues Allocating Its Capital

May 07
Novozymes (CPH:NZYM B) May Have Issues Allocating Its Capital

Novozymes A/S (CPH:NZYM B) Pays A kr.5.25 Dividend In Just Three Days

Mar 07
Novozymes A/S (CPH:NZYM B) Pays A kr.5.25 Dividend In Just Three Days

Do Its Financials Have Any Role To Play In Driving Novozymes A/S' (CPH:NZYM B) Stock Up Recently?

Mar 04
Do Its Financials Have Any Role To Play In Driving Novozymes A/S' (CPH:NZYM B) Stock Up Recently?

Key Things To Consider Before Buying Novozymes A/S (CPH:NZYM B) For Its Dividend

Feb 17
Key Things To Consider Before Buying Novozymes A/S (CPH:NZYM B) For Its Dividend

Has Novozymes (CPH:NZYM B) Got What It Takes To Become A Multi-Bagger?

Feb 03
Has Novozymes (CPH:NZYM B) Got What It Takes To Become A Multi-Bagger?

Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Jan 20
Is Novozymes (CPH:NZYM B) Using Too Much Debt?

The Novozymes (CPH:NZYM B) Share Price Is Up 14% And Shareholders Are Holding On

Jan 05
The Novozymes (CPH:NZYM B) Share Price Is Up 14% And Shareholders Are Holding On

Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Dec 18
Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Shareholder Returns

NZYM BDK ChemicalsDK Market
7D1.4%2.1%-1.7%
1Y-0.7%3.7%16.4%

Return vs Industry: NZYM B underperformed the Danish Chemicals industry which returned 3.7% over the past year.

Return vs Market: NZYM B underperformed the Danish Market which returned 16.4% over the past year.

Price Volatility

Is NZYM B's price volatile compared to industry and market?
NZYM B volatility
NZYM B Average Weekly Movement3.9%
Chemicals Industry Average Movement4.8%
Market Average Movement4.7%
10% most volatile stocks in DK Market9.9%
10% least volatile stocks in DK Market2.6%

Stable Share Price: NZYM B is not significantly more volatile than the rest of Danish stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: NZYM B's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19256,820Ester Baigethttps://www.novozymes.com

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in North America, India, Japan, the Middle East, Africa, South East Asia, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Novozymes A/S Fundamentals Summary

How do Novozymes's earnings and revenue compare to its market cap?
NZYM B fundamental statistics
Market Capkr.99.82b
Earnings (TTM)kr.3.21b
Revenue (TTM)kr.17.83b

31.3x

P/E Ratio

5.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NZYM B income statement (TTM)
Revenuekr.17.83b
Cost of Revenuekr.8.15b
Gross Profitkr.9.67b
Other Expenseskr.6.46b
Earningskr.3.21b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Feb 01, 2024

Earnings per share (EPS)11.58
Gross Margin54.27%
Net Profit Margin18.00%
Debt/Equity Ratio45.5%

How did NZYM B perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

52%

Payout Ratio